Netherlands· NL-e48c7000ec41
Acular 0.5%, oogdruppels, oplossing
A ketorolac product containing ketorolactrometamol, registered in Netherlands by Medcor Pharmaceuticals B.V.. The same ATC class is registered in 12 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Ketorolac is registered in 12 of 19 countries.
Countries holding a registration under ATC S01BC05 (ketorolac), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 7 of them publish a price we can compare per daily dose
Ketorolac · ATC S01BC05
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Italyprice
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of ketorolac costs, country by country.
Normalised to the WHO defined daily dose (0.75 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Ketorolac · price per daily dose (0.75 mg)
USD · FX 28 Sept 2026
- US United States$0.012 (acquisition cost)
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- KETOROLACTROMETAMOL
- Manufacturer
- Medcor Pharmaceuticals B.V.
- Country
- Netherlands (NL)
- ATC code
- S01BC05
- ATC class
- Ketorolac
- Defined daily dose
- 0.75 mg, AT
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id133894//13381
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
81 interactions on record for ketorolac.
Graded by severity as the source publishes them — 81 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ketorolac · interactions on record
81 records
- 81 moderate
Most severe, free to view
- DicoumarolB01AA01moderate
- WarfarinB01AA03moderate
- HeparinB01AB01moderate
- Antithrombin IIIB01AB02moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ketorolac in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesAcularAllergan, Inc.
- United KingdomAcular 0.5% eye dropsSigma Pharmaceuticals Plc
- CanadaACULARABBVIE CORPORATION
- ItalyBENKETOLPHARMABER S.R.L.
- CzechiaKETOROLAC TROMETAMOL BROWN & BURKBrown & Burk IR Limited, Dublin
- SpainACULAR 5 mg/ml COLIRIO EN SOLUCIONAbbvie Spain, S.L.U.
- SwedenCaloket 30 mg/ml Injektions-/infusionsvätska, lösningEQL Pharma AB
- FinlandAcularAllergan Pharmaceuticals Ireland
Authorised across Europe · EMA
The same active substance is authorised in 24 EEA countries. Names it is sold under:
- Austria · Acular, Ketorolac Micro Labs
- Belgium · Aculare, Taradyl
- Bulgaria · Кетоажур, Кеторолак Вижън
- Cyprus · Errkes
- Czechia · Ketorolac Trometamol Brown & Burk
- Germany · Ketorolac Micro Labs, Ketovision
- Denmark · Acular, Caloket
- Estonia · Ketorolac Baxter
- Spain · Acular, Ketorolaco Kabi
- Finland · Caloket, Ketorolac S.A.L.F.
- France · Acular
- United Kingdom (Northern Ireland) · Acular, Ketorolac Trometamol Baxter Healthcare
- Greece · Acular, Errkes
- Ireland · Acular
- Iceland · Toradol
- Italy · Acular, Benketol
- Lithuania · Ketanov, Ketorolac Baxter
- Luxembourg · Aculare, Taradyl
- Latvia · Ketanov, Ketorolac Baxter
- Norway · Caloket, Ketorolac Trometamol S.A.L.F.
- Poland · Ketorolac Trometamol Brown & Burk
- Portugal · Acular, Cetorolac
- Romania · Ketanov, Ketorol
- Sweden · Caloket, Ketorolac S.A.L.F.
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e531d0f0-34fc-46c6-ba99-4daec64b2f20 GET /v1/drugs/e531d0f0-34fc-46c6-ba99-4daec64b2f20?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oogdruppels, oplossing",
"route": "Oculair gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": null,
"strength": null,
"atc_label": "Ketorolac",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg133894",
"excipients": [
"BENZALKONIUMCHLORIDE",
"DINATRIUMEDETAAT 2-WATER",
"NATRIUMCHLORIDE",
"NATRIUMHYDROXIDE (E 524)",
"OCTOXINOL 40",
"WATER, GEZUIVERD",
"ZOUTZUUR (E 507)"
],
"substances": [
"KETOROLACTROMETAMOL"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h133894.pdf",
"authorised_at": "2025/01/29",
"procedure_number": null,
"dispensing_status": "Uitsluitend recept",
"registration_number": "133894//13381",
"additional_monitoring": "N"
}See everything about ketorolac.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.